Exploring Safety & Clinical Benefit of Anti-Influenza Immune Globulin Intravenous in Hospitalized Adults With Influenza A
Conditions:   Influenza A H3N2;   Influenza A H1N1 Interventions:   Biological: FLU-IGIV;   Other: Placebo for FLU-IGIV Sponsor:   Emergent BioSolutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2017 Category: Research Source Type: clinical trials